Illumina Is Moving Toward Higher Ground
Biotechs have been some of the most volatile stocks in 2015, and Illumina has definitely been one of those. After dropping precipitously in September, it has made its way back toward the 200 ma for the third time. The time, though, Illumina may push through heavy resistance. (It’s worth keeping in mind that this name is barely…
Details